Condition: End Stage Renal Disease · Sponsor: Laminate Medical Technologies
VasQ is an external support implant for arteriovenous fistulas created for dialysis access. This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms: * Treatment arm: End to side fistula supported with VasQ * Control: Standard of care end to side fistula
This description comes directly from the study's public registry record.
Galit Itzhaki · +972-3-6344246 · galit@laminatemedical.com
Always discuss trial participation with your own doctor first.
| Fresenius Vascular Care Long Beach | Long Beach, California, United States | Recruiting |
| Sarasota Memorial Hospital | Sarasota, Florida, United States | Recruiting |
| Grady Memorial Hospital | Atlanta, Georgia, United States | Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Recruiting |
| Greenwood Leflore Hospital | Greenwood, Mississippi, United States | Recruiting |
| Azura Surgery Center Las Vegas | Las Vegas, Nevada, United States | Active Not Recruiting |
| Fresenius Vascular Care Columbia | Columbia, South Carolina, United States | Recruiting |
| Houston Methodist Hospital | Houston, Texas, United States | Recruiting |
| Fairlawn Surgery Center | Roanoke, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06516653